Seres Therapeutics logo

Seres Therapeutics share price today

(MCRB)

Seres Therapeutics share price is $0.89 & ₹76.13 as on 28 Dec 2024, 2.30 'hrs' IST

$0.89

-0.04

(-4.04%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Seres Therapeutics share price in Dollar and Rupees. Guide to invest in Seres Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Seres Therapeutics. Get details on the Indian mutual funds that are investing in Seres Therapeutics. Get Analyst recommendations and forecasts along with all the Seres Therapeutics's financials.

Seres Therapeutics share price movements

  • Today's Low: $0.87
    Today's High: $0.93

    Day's Volatility :6.15%

  • 52 Weeks Low: $0.54
    52 Weeks High: $2.05

    52 Weeks Volatility :73.66%

Seres Therapeutics Returns

PeriodSeres Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-6.27%
-9.8%
0.0%
6 Months
22.83%
-4.7%
0.0%
1 Year
-36.66%
1.9%
0.0%
3 Years
-89.35%
-1.8%
-21.3%

Seres Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.9241
Open
$0.93
Today's High
$0.927
Today's Low
$0.87
Market Capitalization
$157.8M
Today's Volume
$1.3M
52 Week High
$2.05
52 Week Low
$0.54
Revenue TTM
$126.3M
EBITDA
$-36.5M
Earnings Per Share (EPS)
$-0.4
Profit Margin
-20.17%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1556.28%

How to invest in Seres Therapeutics from India?

It is very easy for Indian residents to invest directly in Seres Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Seres Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Seres Therapeutics or MCRB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Seres Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Seres Therapeutics shares which would translate to 0.961 fractional shares of Seres Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Seres Therapeutics, in just a few clicks!

Returns in Seres Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Seres Therapeutics investment value today

Current value as on today

₹66,366

Returns

₹33,634

(-33.63%)

Returns from Seres Therapeutics Stock

₹36,429 (-36.43%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Seres Therapeutics

21%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Seres Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 21% more investors are searching Seres Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Seres Therapeutics

  • Flagship Ventures Management, Inc.

    13.54%

  • FMR Inc

    13.39%

  • Vanguard Group Inc

    3.55%

  • BlackRock Inc

    1.03%

  • Geode Capital Management, LLC

    0.81%

  • Susquehanna International Group, LLP

    0.70%

Analyst Recommendation on Seres Therapeutics

Buy

    76%Buy

    15%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Seres Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
1
1
1

Analyst Forecast on Seres Therapeutics

What analysts predicted

Upside of 335.28%

Current:

$0.89

Target:

$3.87

Insights on Seres Therapeutics

  • Price Movement

    In the last 7 days, MCRB stock has moved down by -8.1%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 126.47M → 64.0K (in $), with an average decrease of 89.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -47.85M → 88.77M (in $), with an average increase of 44.5% per quarter
  • MCRB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.3% return, outperforming this stock by 61.0%
  • MCRB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.1% return, outperforming this stock by 128.7%
  • Price to Sales

    ForMCRB every $1 of sales, investors are willing to pay $1.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Seres Therapeutics Technicals Summary

Sell

Neutral

Buy

Seres Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Seres Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Seres Therapeutics Inc
-4.34%
22.83%
-36.66%
-89.35%
-73.53%
Regeneron Pharmaceuticals, Inc.
-6.55%
-32.6%
-21.28%
12.81%
90.81%
Biontech Se
-2.77%
44.55%
1.43%
-55.8%
195.97%
Alnylam Pharmaceuticals, Inc.
-5.94%
-2.2%
22.08%
40.33%
105.82%
Vertex Pharmaceuticals Incorporated
-12.23%
-13.26%
-0.52%
86.14%
86.27%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Seres Therapeutics Inc
NA
NA
-0.11
-0.52
-15.56
-0.1
NA
0.18
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.07
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Seres Therapeutics Inc
Buy
$157.8M
-73.53%
NA
-20.17%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
90.81%
17.67
33.61%
Biontech Se
Buy
$27.3B
195.97%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.3B
105.82%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.8B
86.27%
32.84
-4.51%

About Seres Therapeutics

seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.
Organization
Seres Therapeutics
Employees
233
CEO
Mr. Eric D. Shaff M.B.A.
Industry
Health Technology

Management People of Seres Therapeutics

NameTitle
Mr. Eric D. Shaff M.B.A.
President, CEO & Director
Dr. Lisa von Moltke M.D.
Executive VP & Chief Medical Officer
Dr. Teresa L. Young Ph.D., R.Ph.
Executive VP and Chief Commercial & Strategy Officer
Ms. Marella Thorell CPA
Executive VP & CFO
Dr. Matthew R. Henn Ph.D.
Executive VP & Chief Scientific Officer
Mr. Carlo Tanzi Ph.D.
Investor Relations Officer
Mr. Thomas J. DesRosier Esq., J.D.
Chief Legal Officer, Executive VP & Secretary
Ms. Caroline Holda
Assistant General Counsel

Important FAQs about investing in Seres Therapeutics from India :

What is Seres Therapeutics share price today?

Seres Therapeutics share price today stands at $0.89, Open: $0.93 ; Previous Close: $0.92 ; High: $0.93 ; Low: $0.87 ; 52 Week High: $2.05 ; 52 Week Low: $0.54. The stock opens at $0.93, after a previous close of $0.92. The stock reached a daily high of $0.93 and a low of $0.87, with a 52-week high of $2.05 and a 52-week low of $0.54.

Can Indians buy Seres Therapeutics shares?

Yes, Indians can invest in the Seres Therapeutics (MCRB) from India.

With INDmoney, you can buy Seres Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Seres Therapeutics at zero transaction cost.

How can I buy Seres Therapeutics shares from India?

It is very easy to buy Seres Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Seres Therapeutics be purchased?

Yes, you can buy fractional shares of Seres Therapeutics with INDmoney app.

What are the documents required to start investing in Seres Therapeutics stocks?

To start investing in Seres Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Seres Therapeutics

Today’s highest price of Seres Therapeutics (MCRB) is $0.93.

Today’s lowest price of Seres Therapeutics (MCRB) is $0.87.

What is today's market capitalisation of Seres Therapeutics

Today's market capitalisation of Seres Therapeutics MCRB is 157.8M

What is the 52 Week High and Low Range of Seres Therapeutics

  • 52 Week High

    $2.05

  • 52 Week Low

    $0.54

What are the historical returns of Seres Therapeutics?

  • 1 Month Returns

    -4.34%

  • 3 Months Returns

    22.83%

  • 1 Year Returns

    -36.66%

  • 5 Years Returns

    -73.53%

Who is the Chief Executive Officer (CEO) of Seres Therapeutics

Mr. Eric D. Shaff M.B.A. is the current Chief Executive Officer (CEO) of Seres Therapeutics.